Washington [US], May 27 (ANI): Sodium-glucose transporter-2 (SGLT2) inhibitors, which reduce renal glucose reabsorption, may help control blood sugar and protect kidney health in patients with diabetic renal failure; however, several large clinical trials have linked these drugs to a higher risk of bone fracture.
Washington [US], August 26 (ANI): According to the findings of a new study, adherence to lifestyle advice and medications could add seven healthy years of life after a heart attack.
\
\
\
\
